A Randomized Clinical Trial Investigating the Safety, Reactogenicity, and Immunogenicity After Immunization With an mRNA-based Mpox Vaccine Candidate in Africa

Clinical trial NCT07379580 · RECRUITING

Trial details

NCT number: NCT07379580
Sponsor: BioNTech SE
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Mpox (Monkeypox)Smallpox Orthopoxvirus Infection

Start date: 2026-02-20
Primary completion: 2027-06-01
Enrollment: 310

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.